Compile Data Set for Download or QSAR
Report error Found 29 Enz. Inhib. hit(s) with all data for entry = 11444
TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616862(US20230279024, Example 7)
Affinity DataIC50: 5nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616878(US20230279024, Example 32)
Affinity DataIC50: 5nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616876(US20230279024, Example 30)
Affinity DataIC50: 5nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616873(US20230279024, Example 26)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616887(US20230279024, Example 52)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616886(US20230279024, Example 49)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616885(US20230279024, Example 47)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616882(US20230279024, Example 38)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616881(US20230279024, Example 37)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616880(US20230279024, Example 36)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616879(US20230279024, Example 33)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616877(US20230279024, Example 31)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616875(US20230279024, Example 29)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616872(US20230279024, Example 25)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616871(US20230279024, Example 22)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616870(US20230279024, Example 19)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616869(US20230279024, Example 18)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616868(US20230279024, Example 16)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616867(US20230279024, Example 15)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616865(US20230279024, Example 13)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616864(US20230279024, Example 9)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616863(US20230279024, Example 8)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616860(US20230279024, Example 3)
Affinity DataIC50: 30nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616874(US20230279024, Example 27)
Affinity DataIC50: 75nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616866(US20230279024, Example 14)
Affinity DataIC50: 75nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616884(US20230279024, Example 44)
Affinity DataIC50: 75nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616859(US20230279024, Example 2)
Affinity DataIC50: 100nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616883(US20230279024, Example 40)
Affinity DataIC50: 100nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent

TargetTyrosine-protein kinase receptor UFO(Human)
Beijing Findcure Biosciences

US Patent
LigandPNGBDBM616861(US20230279024, Example 5)
Affinity DataIC50: 100nMAssay Description:The effect of the disclosed compounds as protein kinase inhibitors can be evaluated by the following experiments. The AXL (h) kinase activity of the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/17/2023
Entry Details
Go to US Patent